Acetylcysteine
A medication that replenishes glutathione, a key antioxidant in the body, and is used as the primary antidote for acetaminophen overdose to prevent liver failure. It also thins and loosens thick mucus in the airways, making it useful in conditions such as cystic fibrosis, chronic bronchitis, and to clear mucus before respiratory procedures. When given intravenously for overdose, it is most effective when started within eight hours of ingestion.
Berat Molekul
163,2000 g/mol
LogP
0,40
TPSA
67,40 Ų
Lipinski RO5
Lulus
Area Terapeutik
Mekanisme Kerja
Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.
Struktur 2D
Cite this structure
Embed this structure
SMILES
CC(=O)N[C@@H](CS)C(=O)O
InChI
InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1
Molecular Formula
C5H9NO3S
HBD / HBA
3 / 4
Ikatan yang Dapat Dirotasi
3
Atom Berat
10
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Pertanyaan yang Sering Diajukan
A medication that replenishes glutathione, a key antioxidant in the body, and is used as the primary antidote for acetaminophen overdose to prevent liver failure. It also thins and loosens thick mucus in the airways, making it useful in conditions such as cystic fibrosis, chronic bronchitis, and to clear mucus before respiratory procedures. When given intravenously for overdose, it is most effective when started within eight hours of ingestion.
Counteracts the effects of a specific toxin or drug overdose through competitive antagonism, enhanced elimination, or direct chemical neutralization.
Yes, Acetylcysteine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL600. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 12035. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="acetylcysteine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/acetylcysteine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/acetylcysteine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/acetylcysteine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="acetylcysteine"></drugfyi-drug>